Compare EXPE & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPE | CNC |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1B | 21.5B |
| IPO Year | 2005 | 2001 |
| Metric | EXPE | CNC |
|---|---|---|
| Price | $226.88 | $37.22 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 29 | 17 |
| Target Price | ★ $276.30 | $41.94 |
| AVG Volume (30 Days) | 1.5M | ★ 5.4M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ 9.61 | N/A |
| EPS | ★ 9.81 | N/A |
| Revenue | $14,733,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $10.37 | $8.30 |
| Revenue Next Year | $6.98 | $1.06 |
| P/E Ratio | $23.49 | ★ N/A |
| Revenue Growth | 7.61 | ★ 19.44 |
| 52 Week Low | $144.20 | $25.08 |
| 52 Week High | $303.80 | $63.86 |
| Indicator | EXPE | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 53.90 |
| Support Level | $213.02 | $37.25 |
| Resistance Level | $229.12 | $37.51 |
| Average True Range (ATR) | 10.34 | 1.28 |
| MACD | -0.11 | 0.78 |
| Stochastic Oscillator | 29.69 | 91.83 |
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.